Puretrig Gonadotropin
Category: Injectable Substances
Active ingredient: Human Chorionic Gonadotropin (HCG)
Packaging: 1 ampoule / 5000 IU
Manufacturer: Puretrig
Half-life: 24 to 36 hours
Abused dose: 500 to 1500 IU once every 3 to 5 days
There are 153 products.
Active filters
Category: Injectable Substances
Active ingredient: Human Chorionic Gonadotropin (HCG)
Packaging: 1 ampoule / 5000 IU
Manufacturer: Puretrig
Half-life: 24 to 36 hours
Abused dose: 500 to 1500 IU once every 3 to 5 days
Category: Oral Compounds (Aromatase Inhibitors)
Active ingredient: Exemestane
Packaging: 50 tablets x 25 mg
Manufacturer: General Pharmaceuticals
Half-life: 1 day
Abused dose: most commonly 10 to 20 mg daily or every other day
Category: Injectable compounds (GLP-1, GIP, and glucagon receptor agonist; experimental weight loss medication)
Active ingredient: Retatrutide
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 5–7 days
Dosage: Most commonly 2.5 to 12 mg weekly (typically titrated gradually based on tolerance)
Category: Oral Substances (Eugeroic)
Active Ingredient: Modafinil
Packaging: 10 tablets x 200 mg
Manufacturer: HAB Pharmaceuticals
Half-life: 12 to 15 hours
Abused dose: typically 100 to 200 mg daily
Category: Oral Compounds (Beta-2-adrenergic agonists)
Active ingredient: Clenbuterol
Packaging: 50 tablets x 40 mcg
Manufacturer: General Pharmaceuticals
Half-life: 36 to 48 hours
Abused dose: from 20 to 120 mcg daily
Category: Injectable compounds (GLP-1 and GIP receptor agonist, medication for weight loss support)
Active ingredient: Tirzepatide
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 5 days
Dosage: Most commonly 2.5 to 15 mg weekly (typically starting at 2.5 mg per week with gradual dose escalation based on tolerance)
Category: Injectable Substances (GLP-1 Receptor Agonist, weight-loss medication)
Active Ingredient: Semaglutide
Packaging: Vial containing 4 mg
Manufacturer: General Pharmaceuticals
Half-life: approximately 7 days
Dosage: Most commonly 0.5 to 1 mg weekly (from 0.25 to 1 mg weekly)
Category: Injectable Substances (Peptide Hormone)
Active Ingredient: Thymosin Beta 4
Packaging: Vial containing 10 mg
Manufacturer: General Pharmaceuticals
Half-life: 3.5 to 7 hours
Dosage: Taken at a dose of 2.5 to 6 mg per week, with the dose divided into 2 to 3 doses per week